Abiopharma

Press Release: DiaMedica Therapeutics Provides DM199 Preeclampsia Program Update Following Pre-IND Meeting with FDA

Owlet Baby Care Inc. - Owlet Announces New DME Partnership With 1 Natural Way to Expand Insurance-Supported Access to BabySat®Infant Pulse Oximeter

(90% Positive) DIAMEDICA THERAPEUTICS INC. (DMAC) Announces Enrollment Update for Preparations Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

Biofrontera Inc. Completes Transfer of Ameluz® and RhodoLED® FDA approval and Associated Intellectual Property Portfolio

Owlet Announces New DME Partnership With 1 Natural Way to Expand Insurance-Supported Access to BabySat® Infant Pulse Oximeter

DiaMedica Therapeutics Provides DM199 Preeclampsia Program Update Following Pre-IND Meeting with FDA

(56% Positive) TREACE MEDICAL CONCEPTS, Inc. (TMCI) Announces Business Combination

Elanco Animal Health Inc. - Elancos CredelioQuattro™-CA1 (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) Receives First FDA Conditional Approval for Treatment of New World Screwworm in Dogs

Elancos Credelio Quattro™-CA1 (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) Receives First FDA Conditional Approval for Treatment of New World Screwworm in Dogs

Biodexa Pharmaceuticals PLC (BDRX) Files Form 6-K

(10% Negative) OVID THERAPEUTICS INC. (OVID) Announces Delay in Pharmacokinetics Trials for OV350 were as predicted Due to Geopolitical Situation, Regulatory Process, Safety Review

Intelligent Bio Solutions Inc. - Intelligent Bio Solutions Announces Strategic Partnership with Vlepis, Provider of Advanced Sensing and Wearable Patch Technologies, to Drive Innovation in Non-Invasive Screening and Consumer Health Monitoring

Gilead - Gilead Sciences Appoints Keeley Wettan as Executive Vice President, General Counsel, Legal & Compliance

I-Mab (IMAB) Files Form 6-K

Zoetis - Zoetis to Participate in the 44th Annual J.P. Morgan Healthcare Conference